Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients with unresectable hepatocellular carcinoma

Shinpei Yamaba; Yukinori Imai; Kayoko Sugawara; Yoshihito Uchida; Akira Fuchigami; Hiroshi Uchiya; Nobuaki Nakayama; Satoshi Mochida

doi:10.1371/journal.pone.0298770

Loading metrics

Open Access

Peer-reviewed

Research Article

Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients with unresectable hepatocellular carcinoma

Shinpei Yamaba,

Roles Writing – original draft

Affiliation Faculty of Medicine, Gastroenterology & Hepatology, Saitama Medical University, Iruma-gun, Saitama, Japan

https://orcid.org/0009-0002-0747-7234

⨯
Yukinori Imai,

Roles Writing – review & editing

Affiliation Faculty of Medicine, Gastroenterology & Hepatology, Saitama Medical University, Iruma-gun, Saitama, Japan
⨯
Kayoko Sugawara,

Roles Writing – review & editing

Affiliation Faculty of Medicine, Gastroenterology & Hepatology, Saitama Medical University, Iruma-gun, Saitama, Japan
⨯
Yoshihito Uchida,

Roles Writing – review & editing

Affiliation Faculty of Medicine, Gastroenterology & Hepatology, Saitama Medical University, Iruma-gun, Saitama, Japan
⨯
Akira Fuchigami,

Roles Writing – review & editing

Affiliation Faculty of Medicine, Gastroenterology & Hepatology, Saitama Medical University, Iruma-gun, Saitama, Japan
⨯
Hiroshi Uchiya,

Roles Writing – review & editing

Affiliation Faculty of Medicine, Gastroenterology & Hepatology, Saitama Medical University, Iruma-gun, Saitama, Japan
⨯
Nobuaki Nakayama,

Roles Writing – review & editing

Affiliation Faculty of Medicine, Gastroenterology & Hepatology, Saitama Medical University, Iruma-gun, Saitama, Japan
⨯
Satoshi Mochida

Roles Writing – review & editing

* E-mail: smochida@saitama-med.ac.jp

Affiliation Faculty of Medicine, Gastroenterology & Hepatology, Saitama Medical University, Iruma-gun, Saitama, Japan

https://orcid.org/0000-0002-8792-4526

⨯

Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients with unresectable hepatocellular carcinoma

Shinpei Yamaba,
Yukinori Imai,
Kayoko Sugawara,
Yoshihito Uchida,
Akira Fuchigami,
Hiroshi Uchiya,
Nobuaki Nakayama,
Satoshi Mochida

Published: April 30, 2024
https://doi.org/10.1371/journal.pone.0298770

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Proteinuria
Is the Subject Area "Proteinuria" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Multivariate analysis
Is the Subject Area "Multivariate analysis" applicable to this article?

Thanks for your feedback.
Radiation therapy
Is the Subject Area "Radiation therapy" applicable to this article?

Thanks for your feedback.
Chemotherapy
Is the Subject Area "Chemotherapy" applicable to this article?

Thanks for your feedback.